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symptomatic
olff-Parkinson-White
yndrome in Children
n Unnatural History?*
eshadri Balaji, MBBS, MRCP(UK), PHD, FACC
ortland, Oregon
he management of an asymptomatic child incidentally
iscovered to have Wolff-Parkinson-White (WPW) syn-
rome on electrocardiogram (ECG) is a controversial issue.
ne big impediment to settling the controversy is our
gnorance about the natural history of asymptomatic WPW
yndrome. In this issue of the Journal, Santinelli et al. (1)
eport the largest cohort (to date) of children with asymp-
omatic WPW syndrome intensively followed for a period
f time. Patients were identified incidentally or through the
ass ECG screening program for athletes instituted in Italy
ince 1982.
See page 275
All children (age 8 to 12 years) underwent an electro-
hysiology (EP) study at the start of the prospective
rotocol. They were followed every 6 months with an ECG
nd a 24-h Holter monitor. The primary end point was the
rst arrhythmic event. Over a median follow-up of 57
onths, 51 of 133 children became symptomatic. Of these,
9 had potentially life-threatening arrhythmias. Interest-
ngly, some children with potentially life-threatening ar-
hythmias had minimal (n  5) or atypical symptoms (n 
) such as nausea, sudden tiredness with anxiety, abdominal
ain and swelling, and inability to concentrate while play-
ng. Factors associated with increased risk were the presence
f multiple accessory pathways and an accessory pathway
ffective refractory period (APERP) 240 ms. Atrioven-
ricular re-entry tachycardia (AVRT) inducibility did not
rove significant on multivariate analysis. What are the
essons of this study and how do we incorporate its findings
nto clinical practice? Some background first . . .
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.l
From the Department of Pediatrics (Cardiology), Oregon Health & Science
niversity, Portland, Oregon.While it commonly presents with paroxysmal AVRT,
PW syndrome may rarely cause sudden death (SD) due to
trial fibrillation (AF) being rapidly conducted to the
entricle over the accessory pathway resulting in ventricular
brillation (2,3). In some patients, SD may be the present-
ng symptom. Deal et al. (4) reported 42 SDs in children
ith WPW syndrome. Of these, in 20, SD was the
resenting symptom.
The approach to the asymptomatic patient is now signif-
cantly impacted by the availability of EP and catheter
blation (CA). However, EP and CA are invasive proce-
ures with a potential for complications that could be
nacceptable for the asymptomatic patient; hence, the need
or careful and objective risk-benefit analysis.
EP can help identify patients at risk for developing
ymptoms and SD due to WPW syndrome. Inducibility of
VRT, a shorter APERP (240 ms), a shorter pre-excited
R interval during induced AF (240 ms), the presence of
ultiple pathways, and septal and right-sided pathway
ocations appear to identify a higher-risk group (3,5–7).
Some authorities have suggested that noninvasive risk
tratification with Holter monitoring, exercise stress testing,
nd pharmacologic testing should be performed before
nvasive studies are considered (8). However, the sensitivity
nd specificity of noninvasive testing has been shown to be
oor (9,10).
Transesophageal EP may be a semi-invasive technique to
void the potential vascular complications of intracardiac
P (11). However, transesophageal EP is not entirely risk
ree. High output pacing may be required to activate the
trium from the esophagus, which can be painful and
equires the use of heavy sedation (12).
The group from Milan has recently made major contri-
utions to our understanding of the asymptomatic patient
ith WPW syndrome. They reported the ability of EP
esting to risk stratify asymptomatic patients (13). Of the
62 patients (adults and children) studied, only 4 of the 115
atients noninducible for supraventricular tachycardia
SVT) went on to develop clinical SVT during a mean
ollow-up of 37.7 months. Of the 47 inducible patients, 21
eveloped SVT and 8 AF. And, of these 8 with AF, 2 had
ear-miss SD, and 1 died suddenly.
The same group also showed that prophylactic CA in
symptomatic WPW syndrome patients (children and
dults) reduces the likelihood of arrhythmia (14). Of 37
atients with inducible SVT (at EP study) who underwent
blation, only 2 had SVT at follow-up (both had AV nodal
e-entry tachycardia) while of 35 with inducible SVT
andomized to no treatment, 21 had SVT at follow-up.
Their previous study in children between 5 and 12 years
f age also suggested that prophylactic CA significantly
educes symptoms (15). Of those with inducible SVT, only
of the 27 randomized to ablation developed SVT whereas
of 20 randomized to no treatment did, and 1 from theatter group died suddenly.
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Asymptomatic WPW Syndrome January 20, 2009:281–3The major message of the studies from Milan would be
hat the natural history of asymptomatic WPW syndrome
n children is not benign and that EP study provides
xcellent risk stratification. Patients who are noninducible
ith a long APERP may be followed without treatment,
ut those who are inducible or have a short APERP should
e considered for ablation. This take-home message is at
ariance with previous studies and with current guidelines
rom major cardiology organizations.
Prior studies suggest that SD is rare in an asymptomatic
atient with WPW syndrome. Leitch et al. (16) showed no
Ds in 75 initially asymptomatic patients followed for a
edian of 4.3 years. The population-based study of the
atural history of WPW syndrome by Munger et al. (17)
ad 113 WPW patients of whom 53 were asymptomatic at
etection. While there were 2 SDs in the symptomatic
roup, there were none in the asymptomatic patients.
oudevenos et al. (18) followed 157 patients with inciden-
ally discovered WPW syndrome for an average of 55
onths with no SDs in their cohort. Inoue et al. (19)
ollowed 57 children detected to have WPW syndrome
uring screening ECGs for almost 8 years on average, again
ith no SDs.
Current guidelines from the American Heart Association,
merican College of Cardiology, and the European Society of
ardiology restrict ablation for asymptomatic WPW syn-
rome to those in high-risk occupations and professional
thletes (20). The Heart Rhythm Society expert consensus is
hat ablation for asymptomatic WPW syndrome in children
ge5 years is a class IIB indication and that in those age5
ears it is a class III indication (21).
The main difference between prior studies and the study
f Santinelli et al. (1) is the intensity of monitoring and the
redence given to atypical symptoms, which are often
ismissed as being noncardiac, in the current study. This
tudy, therefore, alerts us to the importance of these atypical
ymptoms in WPW patients.
Interestingly, current practice by pediatric electrophysi-
logists may be more in line with the Milan group recom-
endations. Campbell et al. (22) surveyed the members of
he PACES (Pediatric and Congenital Electrophysiology
ociety) study group. Of 43 respondents (of whom 37 had
een performing ablation for5 years), 36 used EP study to
isk-stratify children with asymptomatic WPW syndrome.
ost (33 of 43, 77%) would also perform ablation on
hildren with a shortest pre-excited RR during AF of 240
m, and 19 of 43 (44%) would have ablated those with
PERP 240 ms. Only 11 of 43 (26%) would ablate those
ith inducible SVT alone. Special consideration of ablation
as given by these physicians to patients considering high-
isk careers; competitive athletes; and those with coexisting
ongenital heart disease, asthma, and attention deficit dis-
rder likely to require medical management with drugs.
There are some caveats to the natural history study by
antinelli et al. (1). First, children 5 years old were
xcluded by design, and all children were 8 years old.econd, there was a high proportion of competitive athletes
icked up during the Italian countrywide ECG screening
rogram for competitive athletes.
In summary, this report by Santinelli et al. (1) further
einforces the notion that children with asymptomatic
PW syndrome should undergo an EP study. However,
rudence dictates that noninvasive testing with Holter and
xercise test (if the Holter does not show intermittent
re-excitation) should be considered before the EP study. It
ay also be wise to consider transesophageal EP rather than
roceeding directly to intracardiac testing. The exact age at
hich the EP study should be done is unclear, but 8 years
eems a reasonable age cutoff. Those who have a potentially
angerous pathway (as defined by the presence of multiple
athways or a short APERP) should probably undergo
blation as long as it is felt to be reasonably safe. The
hysician involved needs to use special care and discretion in
aking this decision and must especially consider the
uccess rate and complication rate in his/her hands. While
uccess rates for CA have been improving, serious compli-
ations still occur in a small minority of patients (23,24).
Lastly, the findings of the Milan group suggest a more
alignant natural history in their cohort than previous
eports (16–19). It is advisable to perform further studies in
ther ethnic/geographic populations before these findings
an be accepted in all countries. Despite these caveats, the
ndings in this study should prompt a reconsideration of
urrent guidelines by professional organizations in the area
f pediatric arrhythmia.
eprint requests and correspondence: Dr. Seshadri Balaji, 707
W Gaines Street, Mailcode: CDRC-P, Portland, Oregon 97239.
-mail: balajis@ohsu.edu.
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